Series date: 
07/01/2020 - 7:00am CDT to 06/30/2021 - 4:00pm CDT
Location

Please check the individual session for location or broadcast availability.  


Frequency

Monthly


Series Director

Christopher Amos, PhD


Target Audience and Needs

Physicians, residents, fellows, scientists, and other health professionals in general practice specialties such as internal medicine, oncology, surgery, and pathology need to be updated about the practice and implementation of precision medicine initiatives to improve the delivery of targeted and individualized care. Health professionals should be aware of the ethical issues that arise in the practice of precision medicine. Testing for genetically influenced diseases can affect personalized management of individuals and their families.


Educational Methods

Educational methods will include lectures.


Objectives

At the conclusion of the sessions, the participants should be able to:

  • Discuss the value and challenges in implementing precision medicine for clinical practice in cancer, and cardiovascular, autoimmune, and neurological diseases. 
  • Support precision medicine practices through enhanced training in genomics, proteomics, and other high-dimensional assays.
  • Explain the fundamentals of precision medicine, the assays used for measurement, and how the results of those assays inform personalized therapy and implement this knowledge in practice.
  • Summarize the ethical and legal issues related to precision medicine and determine how those issues affect patients with disparate family genetic histories and socioeconomic backgrounds.
  • Evaluate the positive results of genetic screening tests for cancer and other hereditary diseases, and design decision support tools to better guide the decision-making of patients with results from precision medicine initiatives including genomics and other multiomics and complex results from imaging or other precise approaches to disease development.
  • Discuss patient-centered care and its relevance to decision support with particular emphasis on applications in oncology.

Evaluation

Participants may be asked to complete a session evaluation.


Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Series Coordinator 

Kathryn Edwards, AA
edwardsa@bcm.edu
713-798-3394

Series location: 
Baylor St. Luke’s Medical Center
6770 Bertner Avenue
Houston, TX 77030
United States

Sessions

Session Date
Lower Cost and Higher Precision Medicine 12/14/2020 - 10:00am to 11:00am CST
New Frontiers in Genetics and Genomics 06/14/2021 - 12:00pm to 1:00pm CDT